The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACHAOGEN INC | COM | 004449104 | 8,561 | 661,054 | SH | SOLE | 661,054 | 0 | 0 | ||
ALLERGAN PLC | SHS | G0177J108 | 15,954 | 94,800 | SH | SOLE | 94,800 | 0 | 0 | ||
ALMOST FAMILY INC | COM | 020409108 | 7,560 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
AMPIO PHARMACEUTICALS INC | COM | 03209T109 | 378 | 111,150 | SH | SOLE | 111,150 | 0 | 0 | ||
ARENA PHARMACEUTICALS INC | COM NEW | 040047607 | 4,756 | 120,400 | SH | SOLE | 120,400 | 0 | 0 | ||
AVEO PHARMACEUTICALS INC | COM | 053588109 | 3,026 | 1,043,550 | SH | SOLE | 1,043,550 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM | 079481107 | 696 | 106,050 | SH | SOLE | 106,050 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 5,140 | 63,400 | SH | SOLE | 63,400 | 0 | 0 | ||
CENTENE CORP DEL | COM | 15135B101 | 2,498 | 23,375 | SH | SOLE | 23,375 | 0 | 0 | ||
CIDARA THERAPEUTICS INC | COM | 171757107 | 4,746 | 1,186,355 | SH | SOLE | 1,186,355 | 0 | 0 | ||
CIGNA CORPORATION | COM | 125509109 | 5,401 | 32,200 | SH | SOLE | 32,200 | 0 | 0 | ||
CIVITAS SOLUTIONS INC | COM | 17887R102 | 2,532 | 164,396 | SH | SOLE | 164,396 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | COM | 189464100 | 2,429 | 46,001 | SH | SOLE | 46,001 | 0 | 0 | ||
CLOVIS ONCOLOGY INC | CALL | 189464900 | 2,640 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
DEXCOM INC | COM | 252131107 | 4,820 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 5,229 | 530,848 | SH | SOLE | 530,848 | 0 | 0 | ||
INOGEN INC | PUT | 45780L954 | 3,206 | 26,100 | SH | Put | SOLE | 26,100 | 0 | 0 | |
INOGEN INC | PUT | 45780L954 | 86 | 700 | SH | Put | SOLE | 700 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 3,546 | 209,842 | SH | SOLE | 209,842 | 0 | 0 | ||
KINDRED HEALTHCARE INC | COM | 494580103 | 1,485 | 162,326 | SH | SOLE | 162,326 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 11,196 | 445,000 | SH | SOLE | 445,000 | 0 | 0 | ||
NABRIVA THERAPEUTICS PLC | SHS | G63637105 | 1,221 | 242,689 | SH | SOLE | 242,689 | 0 | 0 | ||
NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 816 | 233,003 | SH | SOLE | 233,003 | 0 | 0 | ||
PARATEK PHARMACEUTICALS INC | COM | 699374302 | 1,933 | 148,682 | SH | SOLE | 148,682 | 0 | 0 | ||
PIERIS PHARMACEUTICALS INC | COM | 720795103 | 3,845 | 563,763 | SH | SOLE | 563,763 | 0 | 0 | ||
QUOTIENT LTD | SHS | G73268107 | 3,213 | 682,180 | SH | SOLE | 682,180 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 6,107 | 297,750 | SH | SOLE | 297,750 | 0 | 0 | ||
SABRA HEALTH CARE REIT INC | COM | 78573L106 | 10,237 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
SHIRE PLC | SPONSORED ADR | 82481R106 | 21,828 | 146,114 | SH | SOLE | 146,114 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM | 82640U107 | 5,255 | 2,538,525 | SH | SOLE | 2,538,525 | 0 | 0 | ||
TELIGENT INC NEW | COM | 87960W104 | 8,308 | 2,472,561 | SH | SOLE | 2,472,561 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 801 | 34,100 | SH | SOLE | 34,100 | 0 | 0 |